跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge
Approved
STANDARD
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a3d1a78d6f812be5
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a3d1a78d6f812be5
Product Name
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge
Artg Id
39659
Artg Name
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
1992-05-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/484d5d3db5e7a05a451cbbd592512cc2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/955d8182afbb5e6169a673ad1fd37fd9.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a3d1a78d6f812be5
Type
Standard
Back to TGA Approvals
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge - TGA Drug Approval Details